CN Patent

CN116848110A — 氘代集落刺激因子-1受体（csf-1r）抑制剂

Assigned to Genzyme Corp · Expires 2023-10-03 · 3y expired

What this patent protects

本文公开了下式的氘代化合物，所述氘代化合物可用作集落刺激因子1受体抑制剂(“CSF‑1R抑制剂”)。

USPTO Abstract

本文公开了下式的氘代化合物，所述氘代化合物可用作集落刺激因子1受体抑制剂(“CSF‑1R抑制剂”)。

Drugs covered by this patent

Patent Metadata

Patent number
CN116848110A
Jurisdiction
CN
Classification
—
Expires
2023-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.